Results 31 to 40 of about 762,366 (142)

ruvA Mutants that resolve Holliday junctions but do not reverse replication forks [PDF]

open access: yes, 2008
RuvAB and RuvABC complexes catalyze branch migration and resolution of Holliday junctions (HJs) respectively. In addition to their action in the last steps of homologous recombination, they process HJs made by replication fork reversal, a reaction which ...
Bradley Alison Sylvia   +14 more
core   +2 more sources

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities

open access: yesNature Communications, 2022
The molecular landscape of breast cancer brain metastases (BCBM) is still understudied, especially for different breast cancer subtypes. Here, the authors characterise subtype-specific BCBMs using genomics and transcriptomics and identify homologous ...
Nicola Cosgrove   +18 more
doaj   +1 more source

Recombination in enteroviruses is a biphasic replicative process involving the generation of greater-than genome length 'imprecise' intermediates [PDF]

open access: yes, 2014
Recombination in enteroviruses provides an evolutionary mechanism for acquiring extensive regions of novel sequence, is suggested to have a role in genotype diversity and is known to have been key to the emergence of novel neuropathogenic variants of ...
David J Evans   +13 more
core   +1 more source

The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks inmammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136 [PDF]

open access: yes, 2005
SJG-136, a pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimer, is a highly efficient interstrand crosslinking agent that reacts with guanine bases in a 5'-GATC-3' sequence in the DNA minor groove.
Hartley, J.A.   +20 more
core   +1 more source

Supplementary Figure from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response

open access: yes, 2022
Supplementary Figure from Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic ...
Hyeon Gu Kang (14956288)   +11 more
core   +1 more source

Enhanced radiosensitivity of head and neck cancer cells to proton therapy via hyperthermia-induced homologous recombination deficiency

open access: yesClinical and Translational Radiation Oncology
Background and purpose: Radiotherapy induces tumor cell killing by generating DNA double strand breaks (DSBs). The effectiveness of radiotherapy is significantly influenced by the repair of DSBs, which counteracts this lethal effect.
Tim Heemskerk   +4 more
doaj   +1 more source

SMYD3 Promotes Homologous Recombination via Regulation of H3K4-mediated Gene Expression

open access: yesScientific Reports, 2017
SMYD3 is a methyltransferase highly expressed in many types of cancer. It usually functions as an oncogenic protein to promote cell cycle, cell proliferation, and metastasis.
Yun-Ju Chen   +3 more
doaj   +1 more source

Biomarkers for Homologous Recombination Deficiency in Cancer

open access: yes, 2021
DNA double-strand breaks foster tumorigenesis and cell death. Two distinct mechanisms can be activated by the cell for DNA repair: the accurate mechanism of homologous recombination repair or the error-prone non-homologous end joining.
Svenja Wagener-Ryczek   +2 more
core   +1 more source

Homologous Recombination Deficiency, Genetics, PARP Inhibitors, and Screening in Cancer

open access: yes, 2023
Homologous Recombination Deficiency, Genetics, PARP Inhibitors, and Screening in Cancer, Amy Bodrog, MD, Lipson Cancer Institute Objectives: Discuss how PARP inhibitors work.
Bodrog, Amy
core  

Feasibility and cost-effectiveness of genetic counselling for all patients with newly diagnosed ovarian cancer: a single-centre retrospective study

open access: yesSwiss Medical Weekly
BACKGROUND AND AIMS OF THE STUDY: Due to its importance for treatment and potential prevention in family members, germline testing for BRCA1/2 in patients with newly diagnosed ovarian cancer is decisive and considered a standard of care.
Saskia Schlootz   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy